| Jonathan D. Adachi |
|
Corticosteroid-induced Osteoporosis |
| Steven Boonen |
|
Clinical Aspects of Osteoporosis in the Oldest Old |
| Steve R. Cummings |
|
Future Treatments for Osteoporosis |
| John A. Eisman |
|
Genetic Aspects of Osteoporosis |
| Dieter Felsenberg |
|
Disuse, Low gravity and Bone |
| Harry K. Genant |
|
Vertebral Fracture Assessment |
| F. Jiwa and Alexandra Papaioannou |
|
What makes a successful osteoporosis strategy?
A model for Government and Societies
|
| Marius Kraenzlin |
|
Practical Use of Osteodensitometry |
| Paul Lips |
|
Evaluation of Quality of Life |
| L. Joseph Melton |
|
Epidemiology of Osteoporosis: Study Design |
| Lawrence G. Raisz |
|
Practical Use of Biochemical Markers |
| Ego Seeman |
|
Bone Architecture, Matrix Properties and Fracture Risk |
| Elisabeth Shane |
|
Secondary Causes of Osteoporosis |
| John P. Bilezikian |
|
Bone Anabolic Treatments and its Monitoring |
| Jean-Philippe Bonjour |
|
Bone Growth in Childhood and Adolescence |
| Peter Burckhardt |
|
Calcium and Vitamin D in Osteoporosis Management |
| Juliet E. Compston |
|
Management of Osteoporosis before Menopause |
| Judith Cranford and Karen Ormerod |
|
Actions to Make Osteoporosis a Priority on Payers' Healthcare Agenda |
| Bess Dawson-Hughes |
|
Nutrition Counselling of Osteoporotic Patients |
| Richard Eastell |
|
Compliance to Osteoporosis Therapy |
| David Marsh |
|
Post Fracture Management |
| M. Pfeifer |
|
Physical Rehabilitation and Prevention of Falls |
| Eric Orwoll |
|
Osteoporosis in Men |
| Jean-Yves Reginster |
|
Current Management of Osteoarthritis |
| Ethel Siris |
|
Place of HRT in the management of osteoporosis |
| Jonathan Adachi and Anthony B. Hodsman |
|
Cost-Utility of Anabolic Treatment |
| Silvano Adami |
|
Management of Osteogenesis Imperfecta in Adults |
| Claude Arnaud |
|
Combination or Sequential Therapy in Osteoporosis |
| Fredrik Borgström |
|
Cost-Utility of Osteoporosis Treatment |
| Maria Luisa Brandi |
|
Pharmacogenetics |
| Cyrus Cooper |
|
Epidemiology and Health Impact of Osteoarthritis |
| David Goltzman |
|
New Therapeutic Targets in Osteoporosis |
| To be announced |
|
Burden of Osteoporosis and Health Economics |
| Robert G. Josse |
|
Cancer Treatment-induced Bone Loss |
| Uri Liberman |
|
Case-Solving Studies |
| Paul D. Miller |
|
Bisphosphonates in Renal Osteodystrophy |
| Nelson B. Watts |
|
How Long Should We Treat? |
